| 1 |
Chen W, Zheng R, Baade PD, et al. Cancer statistics in China, 2015 [J]. CA Cancer J Clin, 2016, 66(2): 115-132.
|
| 2 |
刘荣，刘渠，王子政. 恶性肿瘤多元饱和治疗理念的探索 [J/CD]. 中华腔镜外科杂志(电子版), 2020, 13(3): 129-131.
|
| 3 |
Adam R, Gramont A, Figueras J, et al. Managing synchronous liver metastasis from colorectal cancer: a multidisciplinary international consensus [J]. Cancer Treat Rev, 2015, 41(9): 729-741.
|
| 4 |
Benson AB, Venook AP, Al-Hawary MM, et al. NCCN guidelines insights: colon cancer, version 2.2018 [J]. J Natl Compr Canc Netw, 2018, 16(4): 359-369.
|
| 5 |
Loupakis F, Cremolini C, Masi G, et al. Initial therapy with folfoxiri and bevacizumab for metastatic colorectal cancer [J]. N Engl J Med, 2014, 371(17): 1609-1618.
|
| 6 |
Martin R, Paty P, Fong Y, et al. Simultaneous liver and colorectal resection are safe for synchronous colorectal liver metastasis [J]. J Am Coll Surg, 2003, 197(2): 233-241.
|
| 7 |
Reddy SK, Pawlik TM, Zorzi D, et al. Simulataneous resec tions of colorectal cancer and synchronous liver metastasis: a multi-institutional analysis [J]. Ann Surg Oncol, 2007, 14: 3481-3491. DOI：
10.1245/s10434-007-9517-2.
|
| 8 |
Raoux L, Maulat C, Mokrance FZ, et al. Impact of the strategy for curative treatment of synchronous colorectal cancer liver metastases [J]. J Visc Surg, 2020, 157(4): 289-299.
|
| 9 |
Mentha G, Majno PE, Andres A, et al. Neoadjuvant chemotherapy and resection of advanced synchronous liver metastases before treatment of the colorectal primary [J]. Br J Surg, 2006, 93: 872-878. DOI：
10.1002/bjs.5771.
|
| 10 |
Welsh FK, Chandrakumaran K, John TG, et al. Propensity scorematched outcomes analysis of the liver-first approach for synchronous colorectal liver metastases [J]. Br J Surg, 2016, 103(5): 600-606.
|
| 11 |
刘荣，刘渠，王斐. 预后控制外科：从理论到实践 [J]. 科学通报，2019, 64(11): 1137-1148.
|
| 12 |
Chun YS, Vauthey JN, Boonsirikamchai P, et al. Association of computed tomography morphologic criteria with pathologic response and survival in patients treated with bevacizumab for colorectal liver metastases [J]. JAMA, 2009, 302(21):2338-2344.
|
| 13 |
Moro A, Mehta R, Tsilimigras D, et al. Prognostic factors differ according to kras mutational status: a classification and regression tree model to define prognostic groups after hepatectomy for colorectal liver metastasis [J]. Surgery, 2020, 168(3): 497-503.
|
| 14 |
Spelt L, Nilsson J, Andersson R, et al. Artificial neural networks-a method for prwediction of survival following liver resection for colorectal cancer metastases [J]. Eur J Surg Oncol, 2013, 39(6): 648-654.
|